New Drug Application Filed for “Vemurafenib” for the Treatment of Melanoma with BRAFV600 Mutation and a Companion Diagnostic to Detect the BRAF Mutation
Apr 09, 2014
New Drug Application Filed for “Vemurafenib” for the Treatment of Melanoma with BRAFV600 Mutation and a Companion Diagnostic to Detect the BRAF Mutation
New Drug Application Filed for “Vemurafenib” for the Treatment of Melanoma with BRAFV600 Mutation and a Companion Diagnostic to Detect the BRAF Mutation
